Signalling molecule
Noggin
A BMP antagonist that binds the ligand into inactive complexes
Hypotheses on this target 1
Lower level
Synthesis suppression
Neutralisation
Supplementation1
Accelerated excretion
Supplementation1
Clearing early senescent cells may disrupt bone repair by erasing spatial differentiation cues
Where this hypothesis actsThe callus after early senescent-cell clearance, as the initially tested BMP antagonist
What is proposedReconstruct the spatial distribution of noggin alongside BMP
With whatTargeted delivery
HowUse spatially patterned noggin and BMP protein delivery to reconstruct ligand sources and antagonistic boundaries
Possible resultPossible restoration of the differentiation boundary and mechanically continuous bone bridging
2026-10-03